Skip to content

IMPRODENT

Active Private limited companyfounded 2010active for 16 yearsBeselarestraat 273A, 8980 ZonnebekeKBO/BCE: BE 0830.404.033 #7 employer in Zonnebeke, Wholesale and retail trade sector

Lifetime

15 annual accounts with figures on one time axis
peak of €670,953 in 2026
€670,953▲ 17.7%
peak of €119,911 in 2021
€82,343▲ 28.7%
peak of €554,229 in 2026
€554,229▲ 17.4%
€1.3m▼ 2.1%
peak of 6.5 FTE in 2023
5.7 FTE▲ 7.5%
Board2 names since 2010
2 directors and 1 other
Documentsfilings and deeds
29-10-20262 days before the deadline
2026abbreviated format
Gross margin from €570,249 to €670,953Result from €63,997 to €82,343Equity from €471,885 to €554,229

Key points

from the 2026 annual accounts

Equity

€554,229 ▲ 17.4%

IMPRODENT has made a profit in every financial year since 2012.

Turnover

≈ €3.4m estimated

The abbreviated format states no turnover.

Filings

15 annual accounts since 2012
deadline201520202025

The last five annual accounts were filed 2 to 42 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 10,916 companies had the same profile as IMPRODENT has now. Each dot stands for 28 companies, two years later.

95.1%
were still trading
4.1%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit under 5% of the balance sheet
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 10,916 companies, not a prediction for IMPRODENT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
  • 99 sharesdeed of 28-10-2010
  • 1 sharedeed of 28-10-2010
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0830404033
appointed as director General meeting of 14-12-2022 · Gazette deed
resigns as director reappointed as director · Discharge granted to · Gazette deed
New establishment in Zonnebeke Beselarestraat 332
All 27 events

Comparable companies

same main activity, similar in size and age
Company
IMPRODENT Zonnebeke €1.8m €670,953 30.4% 5.7
VITA NOVA SUPRA Beringen €1.8m €830,674 62.3% 7.3
HYSOP Kuurne €2.5m €783,159 45.8% 7
EUREKA PHARMA Kuurne €1.9m €721,369 85.5% 7.2
PRIMROSE FARMA BELGICA Torhout €1.2m €381,888 74.1% 5.4
OMC Kortrijk €2.7m €866,208 39.5% 8.6
SERGE HUGARD MANAGEMENT CONSULTING Mont-Saint-Guibert €1.7m €712,183 48.1% 3.9

These companies have the same main activity as IMPRODENT: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €1.2m and €2.7m, founded between 2005 and 2012.

Official details

Source: KBO
Status
Active since 19-10-2010Normal situation
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Joint committee
149.04Metal trade · annual accounts 31-03-2026
Establishment units
2.193.056.9648980 Zonnebeke, since 15-10-2010
2.324.280.9408980 Zonnebeke, since 23-11-2021
Financial year end
31 March
Peppol
Reachable since 04-12-2025
Company details

Annual accounts to 31-03-2026

€1.8m▲ 3.1%
Employeeson 31-03-2026
6=
Filing
Filed on 29-10-2026, 2 days before the end of the filing period
Financials

Insights on IMPRODENT

IMPRODENT files the abbreviated format. That format states no turnover. The gross margin rose from €363,519 in 2012 to €670,953 in 2026.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about IMPRODENT

What is the company number of IMPRODENT?
The company number of IMPRODENT is 0830.404.033. The VAT number is the same number with BE in front: BE 0830.404.033.
Where is IMPRODENT based?
The registered office is at Beselarestraat 273A, 8980 Zonnebeke.Company details
What does IMPRODENT do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of IMPRODENT?
IMPRODENT is a private limited company (BV).
When was IMPRODENT founded?
IMPRODENT was founded on 19-10-2010.
Is IMPRODENT still active?
Yes, IMPRODENT is an active enterprise in the KBO register.
How many employees does IMPRODENT have?
IMPRODENT had an average of 5.7 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
Which joint committee does IMPRODENT fall under?
In its 31-03-2026 annual accounts, IMPRODENT states joint committee 149.04 (Metal trade).
What is the turnover of IMPRODENT?
The turnover in financial year 2026 is about €3.4m. This figure is estimated from the gross margin of €670,953 and 35 comparable companies (NACE 464). It probably lies between €2.3m and €4.7m.
Is IMPRODENT profitable?
In financial year 2026, IMPRODENT made a profit of €82,343.
Where can I find the annual accounts of IMPRODENT?
IMPRODENT filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
When are the next annual accounts of IMPRODENT due?
IMPRODENT must file the annual accounts for financial year 2027 by 31-10-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.